Purchase of Imtakt Liquid Chromatography Columns
CDC · CDC OFFICE OF ACQUISITION SERVICES
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 2026-Q-99318 in this department, oldest first.
- Jul 22, 2026 · this noticePre-solicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
The Center for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) intends to award a sole source purchase order to the Herman-Robbins, LLC (dba Imtakt USA), 500 SW 116th Ave, Portland, OR, 97225 for the purchase of Purchase of Imtakt Liquid Chromatography Columns. The authority for this sole source acquisition is in accordance with FAR Part 12.102(a). The program requires replacement Imtakt Unison UK-C-18 and Cadenza HS-C18 liquid chromatography columns, which are consumable items depleted through routine use in assays that detect a… (show all)
nd measure antiretroviral drugs in biological specimens. These assays were developed and validated specifically using these column products, and method validation for the testing is tied directly to the exact column chemistry used during development; substituting a different column could alter retention time, resolution, and reproducibility, requiring costly and time-prohibitive revalidation and risking disruption to ongoing antiretroviral drug monitoring where result accuracy and consistency are critical. Imtakt Unison UK-C-18 and Cadenza HS-C18 columns are proprietary products manufactured by Imtakt Corporation, and Imtakt USA is the sole authorized source through which these exact columns can be procured; therefore, Imtakt USA is the only responsible source capable of supplying the replacement columns needed to maintain the validity and continuity of the program's existing assays. As a result of this synopsis, no competitive solicitation will be posted on sam.gov. We will issue only one solicitation to the identified entity. However, responsible sources that believe they can meet these requirements are encouraged to identify themselves and give written notice by providing a capability statement to the Contracting Officer by the closing date of this posting. The Contracting Officer will not respond to verbal request. All requests must be in writing. A determination by the Government not to compete this proposed action will be based on responses to this notice and are solely within the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Inquiries shall be sent to Liubov Kriel by email at vyh1@cdc.gov and reference solicitation #2026-Q-97212 on the subject line.
Who won similar work
111 award notices on SAM.gov in the last 24 months. Match: Same agency (CDC), any industry: a loose match.
Loose match: same agency, any industry. Read the titles before treating these as competitors.
| Winner | Awards | Value | Last |
|---|---|---|---|
| POLOLEI SOLUTIONS, LLC | 5 | $3.3M | Jul 21, 2026 |
| GLAXOSMITHKLINE, LLC | 3 | $1.7B | Mar 27, 2026 |
| RESEARCH TRIANGLE INSTITUTE Durham NC 27709 USA | 3 | $9.8M | Jun 4, 2026 |
| MERCK SHARP & DOHME LLC · $MRK | 2 | $4.5B | Sep 14, 2026 |
| Pfizer New York NY 10001 USA | 2 | $1.2B | Jun 3, 2026 |
| SEQIRUS USA INC | 2 | $663.9M | Dec 31, 2024 |
| Moderna Princeton NJ 08540 USA | 2 | $314.2M | Jun 3, 2026 |
| SANOFI PASTEUR INC. | 2 | $233.3M | Dec 31, 2024 |
| AMERICAN TYPE CULTURE COLLECTION Manassas VA 20110 USA | 2 | $155.3M | May 18, 2026 |
| ASTRAZENECA PHARMACEUTICALS LP | 2 | $61.0M | Dec 31, 2024 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Sep 28, 2026SPN SOLUTIONS INC$992KModernized VAERS Reporting Application
- Sep 28, 2026PREMIER HEALTHCARE SOLUTIONS, INC$4.2MComprehensive Encounter-level Inpatient and Hospital-based Outpatient Billing and Chargemaster Database for Addressing Public Health Priorities
- Sep 21, 2026Precision Delivery Federal LLC$296KMarket forecast analyses for West Nile virus (WNV) vaccine and anti-WNV monoclonal antibody for prophylaxis
- Sep 15, 2026NEW TECH SOLUTIONS, INC.$195KNetwork Analysis Tool
- Sep 14, 2026MERCK SHARP & DOHME LLC$9.5MMerck Stockpile Vaccine Storage and Rotation Contract
- Sep 11, 2026Johnson Controls Building Automation Systems, LLC$1.9MCCURE PACS Software Support Agreement (Smart Cards)
- Sep 9, 2026DECISIONPOINT CORPORATION$28.1MDEO/ORR All Hazards Labor Support
- Aug 31, 2026RELI GROUP INC$2.2MRisk Management Framework and Cloud Security Operations Support Services
- Aug 24, 2026BANYAN COMMUNICATIONS, INC.$2.5MDFWED Communication Services
- Jul 28, 2026MANHATTAN TORCON A JOINT VENTURE Arlington VA 22201 USA$491.8MConstruction of High-Containment Continuity Laboratory, Building 28 - CDC Roybal Campus, Atlanta, GA
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Centers For Disease Control & Prevention (CDC) since 2024 (4 filings)
- 0 of their lobbyists list a past Centers For Disease Control & Prevention (CDC) job
- $99K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.